Loading...

Chad Christine, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentNeurology
Address400 Parnassus Avenue
San Francisco CA 94117
Phone415-353-9046
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Cornell UniversityM.D.1991School of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    Parkinson's Disease Neuroprotection Clinical Trial
    NIH/NINDS U10NS044460Sep 15, 2002 - Nov 30, 2015
    Role: Co-Principal Investigator
    MECHANISMS UNDERLYING HOMOSYNAPTIC LONG TERM DEPRESSION
    NIH K08NS001813Jul 1, 1995 - May 31, 2000
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fernández-Fournier M, Perry DC, Tartaglia MC, de May M, Boxer A, Coppola G, Christine C, Huang EJ, Seeley WW, Miller BL, DeArmond SJ, Grinberg LT, Geschwind MD. Precipitous Deterioration of Motor Function, Cognition, and Behavior. JAMA Neurol. 2017 Mar 06. PMID: 28264087.
      View in: PubMed
    2. Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine C, Dhall R, Umeh CC, Boyd JT, Stover N, Leehey M, Zweig RM, Nicholas AP, Bodis-Wollner I, Willis A, Kieburtz K, Tilley BC. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. J Parkinsons Dis. 2016 Nov 30. PMID: 27911341.
      View in: PubMed
    3. Wills AA, Elm JJ, Ye R, Chou KL, Parashos SA, Hauser RA, Bodis-Wollner I, Hinson VK, Christine C, Schneider JS. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1. Parkinsonism Relat Disord. 2016 Oct 8. PMID: 27743701.
      View in: PubMed
    4. Goudreau JL, Pérez A, Aminoff MJ, Boyd JT, Burau KD, Christine C, Leehey M, Morgan JC. Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America. J Neurol Sci. 2016 Jul 15; 366:74-81. PMID: 27288780.
      View in: PubMed
    5. Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine C, Cines M, Dahodwala N, Derwent L, Dewey RB, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA. 2015 Feb 10; 313(6):584-93. PMID: 25668262; PMCID: PMC4349346.
    6. Fang JY, Pérez A, Christine C, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL. Parkinson's disease severity and use of dopaminergic medications. Parkinsonism Relat Disord. 2015 Mar; 21(3):297-9. PMID: 25541182; PMCID: PMC4340731 [Available on 03/01/16].
    7. Umeh CC, Pérez A, Augustine EF, Dhall R, Dewey RB, Mari Z, Simon DK, Wills AM, Christine C, Schneider JS, Suchowersky O. No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial. PLoS One. 2014; 9(12):e112287. PMID: 25486269; PMCID: PMC4259292.
    8. Moonen AJ, Wijers A, Leentjens AF, Christine C, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano Ramos C, Shulman L, Singer C, Slevin J, McDonald W, Auinger P, Richard IH. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism Relat Disord. 2014 Jun; 20(6):644-6. PMID: 24679737.
      View in: PubMed
    9. Sidorsky TI, Christine C, Epstein JH, Berger TG. Development of corticobasal syndrome in a patient with congenital erythropoietic porphyria. Parkinsonism Relat Disord. 2014 Mar; 20(3):349-50. PMID: 24388147.
      View in: PubMed
    10. Hess CP, Christine C, Apple AC, Dillon WP, Aminoff MJ. Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging. AJNR Am J Neuroradiol. 2014 May; 35(5):897-903. PMID: 24356677.
      View in: PubMed
    11. Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R, Christine C, Aminoff MJ, Hellerstein MK. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012 Sep; 122(9):3159-69. PMID: 22922254; PMCID: PMC3428100.
    12. Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, Panisset M, Christine C, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, McDonald W. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012 Apr 17; 78(16):1229-36. PMID: 22496199; PMCID: PMC3324323.
    13. Mittermeyer G, Christine C, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther. 2012 Apr; 23(4):377-81. PMID: 22424171; PMCID: PMC4530392.
    14. Christine C, Marks WJ, Ostrem JL. Development of Parkinson's disease in patients with Narcolepsy. J Neural Transm (Vienna). 2012 Jun; 119(6):697-9. PMID: 22231845.
      View in: PubMed
    15. Hegde M, Glass GA, Dalmau J, Christine C. A case of slow orthostatic tremor, responsive to intravenous immunoglobulin. Mov Disord. 2011 Jul; 26(8):1563-5. PMID: 21469203.
      View in: PubMed
    16. Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, Lyons KE, Christine C, Pahwa R, Bodis-Wollner I, Oertel WH, Suchowersky O, Aminoff MJ, Malaty IA, Friedman JH, Okun MS. Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord. 2011 Jul; 17(6):440-5. PMID: 21458353; PMCID: PMC3895941.
    17. Aminoff MJ, Christine C, Friedman JH, Chou KL, Lyons KE, Pahwa R, Bloem BR, Parashos SA, Price CC, Malaty IA, Iansek R, Bodis-Wollner I, Suchowersky O, Oertel WH, Zamudio J, Oberdorf J, Schmidt P, Okun MS. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011 Mar; 17(3):139-45. PMID: 21159538; PMCID: PMC3070297.
    18. Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine C, Forsayeth J, Richardson RM, Su X, Aminoff MJ, Bankiewicz KS. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery. 2010 Nov; 67(5):1377-85. PMID: 20871425.
      View in: PubMed
    19. Christine C, Garwood ER, Schrock LE, Austin DE, McCulloch CE. Parkinsonism in patients with a history of amphetamine exposure. Mov Disord. 2010 Jan 30; 25(2):228-31. PMID: 20063432; PMCID: PMC2831101.
    20. Ostrem JL, Christine C, Glass GA, Schrock LE, Starr PA. Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder. Stereotact Funct Neurosurg. 2010; 88(1):51-5. PMID: 20051710.
      View in: PubMed
    21. Christine C, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009 Nov 17; 73(20):1662-9. PMID: 19828868; PMCID: PMC2839805.
    22. Kao AW, Racine CA, Quitania LC, Kramer JH, Christine C, Miller BL. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer Dis Assoc Disord. 2009 Oct-Dec; 23(4):365-70. PMID: 19935145; PMCID: PMC2886667.
    23. Christine C, Langston JW, Turner RS, Starr PA. The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. J Neurosurg. 2009 Feb; 110(2):234-8. PMID: 19099380; PMCID: PMC2908499.
    24. Eberling JL, Jagust WJ, Christine C, Starr P, Larson P, Bankiewicz KS, Aminoff MJ. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology. 2008 May 20; 70(21):1980-3. PMID: 18401019.
      View in: PubMed
    25. Nakamura K, Christine C, Starr PA, Marks WJ. Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease. Mov Disord. 2007 Apr 15; 22(5):619-26. PMID: 17230483.
      View in: PubMed
    26. Garwood ER, Bekele W, McCulloch CE, Christine C. Amphetamine exposure is elevated in Parkinson's disease. Neurotoxicology. 2006 Dec; 27(6):1003-6. PMID: 16620991.
      View in: PubMed
    27. Lieberman MA, Winzelberg A, Golant M, Wakahiro M, DiMinno M, Aminoff M, Christine C. Online support groups for Parkinson's patients: a pilot study of effectiveness. Soc Work Health Care. 2005; 42(2):23-38. PMID: 16390834.
      View in: PubMed
    28. Christine C, Aminoff MJ. Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance. Am J Med. 2004 Sep 15; 117(6):412-9. PMID: 15380498.
      View in: PubMed
    29. Theodosopoulos PV, Marks WJ, Christine C, Starr PA. Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease. Mov Disord. 2003 Jul; 18(7):791-8. PMID: 12815658.
      View in: PubMed
    30. Starr PA, Christine C, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg. 2002 Aug; 97(2):370-87. PMID: 12186466.
      View in: PubMed
    31. Lissin DV, Gomperts SN, Carroll RC, Christine C, Kalman D, Kitamura M, Hardy S, Nicoll RA, Malenka RC, von Zastrow M. Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors. Proc Natl Acad Sci U S A. 1998 Jun 9; 95(12):7097-102. PMID: 9618545; PMCID: PMC22752.
    32. Christine C, Choi DW. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci. 1990 Jan; 10(1):108-16. PMID: 1688929.
      View in: PubMed
    33. Choi DW, Monyer H, Giffard RG, Goldberg MP, Christine C. Acute brain injury, NMDA receptors, and hydrogen ions: observations in cortical cell cultures. Adv Exp Med Biol. 1990; 268:501-4. PMID: 2150160.
      View in: PubMed
    Chad's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP